Julie Elizabeth Buring is an American epidemiologist and professor at the Harvard T.H. Chan School of Public Health.[1]
Biography
Buring works with Harvard Medical School and Brigham and Women's Hospital. She is a professor in the epidemiology department at Harvard and also a professor at the Boston University School of Public Health.[2][3] She is the chair of the Institutional Review Board of Harvard Medical School.[4][5] She graduated from Pomona College (BA), University of Washington (MS), and the Harvard School of Public Health (ScD).[6]
Research
The focus of Buring's research is the prevention of cardiovascular disease and cancers in women.[4] She connects risk factors such as stroke and blood pressure into her investigation of cardiology. Two of her most well-known clinical trials are a randomized trial of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer, along with the use of vitamin D in the prevention of cardiovascular disease and cancer.[7][3]
Awards
Buring received an honorary doctorate from Pomona College.[1] She received the John Snow Award in Epidemiology from the American Public Health Association.[3]
References
- 1 2 "Julie Elizabeth Buring". Harvard T.H. Chan School of Public Health. 2021-01-05. Retrieved 2023-08-12.
- ↑ "Julie E. Buring, ScD". Boston University School of Public Health. Retrieved 28 April 2023.
- 1 2 3 "Julie E. Buring". Harvard School of Public Health. Retrieved 28 April 2023.
- 1 2 "Julie Buring – Society for Epidemiologic Research". Retrieved 2023-04-17.
- ↑ "Julie Buring, ScD". Boston University. Retrieved 29 April 2023.
- ↑ https://www.bu.edu/sph/profile/julie-buring/
- ↑ Buring, Julie E. (2012-06-12). "Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women". Brigham and Women's Hospital, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI).
{{cite journal}}
: Cite journal requires|journal=
(help)